Biologic Therapies: Lessons from Multiple Sclerosis

Publisher： Karger

E-ISSN： 1421-9875|30|4|383-386

ISSN： 0257-2753

Source： Digestive Diseases, Vol.30, Iss.4, 2012-07, pp. : 383-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Disease-Modifying Therapies in Relapsing Remitting Multiple Sclerosis: A Systematic Comparison

By  

European Neurology, Vol. 60, Iss. 1, 2008-04 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

On the Historical Succession of Vessel-Based Therapies in the Treatment of Multiple Sclerosis

By  

European Neurology, Vol. 70, Iss. 1-2, 2013-05 ,pp. : 48-58

Karger

Access to resources Recommend Favorite

Switching to Second-Line Therapies in Interferon-Beta-Treated Relapsing-Remitting Multiple Sclerosis Patients

By  

European Neurology, Vol. 61, Iss. 3, 2009-01 ,pp. : 177-182

Karger

Access to resources Recommend Favorite

Adherence to Disease-Modifying Therapies in Spanish Patients with Relapsing Multiple Sclerosis: Two-Year Interim Results of the Global Adherence Project

By  

European Neurology, Vol. 65, Iss. 2, 2011-01 ,pp. : 59-67

Karger

Access to resources Recommend Favorite

Low-Dose Gabapentin Combined with either Lamotrigine or Carbamazepine Can Be Useful Therapies for Trigeminal Neuralgia in Multiple Sclerosis

By  

European Neurology, Vol. 44, Iss. 1, 2000-07 ,pp. : 45-48

Karger

Access to resources Recommend Favorite